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Abstract Autopsy series of consecutive cases have
demonstrated an incidence of myocarditis at approximately
1–10%; on the contrary, myocarditis is seriously underdi-
agnosed clinically. In a traditional view, the gold standard
has been myocardial biopsy. However, it is generally
speciﬁc but invasive and less sensitive, mostly because of
the focal nature of the disease. Thus, non-invasive
approaches to detect myocarditis are necessary. The tra-
ditional diagnostic tools are electrocardiography, labora-
tory values, especially troponin T or I, creatine kinase and
echocardiography. For a long period, nuclear technique
with indium-111 antimyosin antibody has been used as a
diagnostic approach. In the last years, the use of this
technique has declined because of radiation exposure and
48-h delay in obtaining imaging after injection to prevent
blood pool effect. Thus, a non-invasive diagnostic
approach without radiation and online image availability
has been awaited. Cardiac magnetic resonance imaging has
these promising characteristics. With this technique, it is
possible to analyse inﬂammation, oedema and necrosis in
addition to functional parameters such as left ventricular
function, regional wall motion and dimensions. Thus,
cardiovascular magnetic resonance imaging has emerged
as the most important imaging tool in the diagnostic pro-
cedure and the review focus on this ﬁeld. But there are also
advances in echocardiography and computer tomography,
which are described in detail.
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Introduction
Acute myocarditis may cause substantial myocardial
damage and can lead to arrhythmias, sudden cardiac death
in the acute phase and to dilated cardiomyopathy in the
acute and chronic phase [1, 2]. Therefore, early diagnosis is
of particular clinical importance. Myocarditis can be
diagnosed with certainty only by endomyocardial biopsy,
which must be examined by histological, immunohisto-
logical and molecular techniques to obtain maximal sen-
sitivity. Due to the often focal localisation of the disease,
sampling error may occur. Furthermore, myocardial biopsy
is in practise used only rarely, despite a low complication
rate [3]. Thus, the diagnosis of myocarditis is often based
merely on suspicion.
Viral myocarditis is found after respiratory or gastroin-
testinal infection with a wide range of viruses. In the
seventies, the RNA virus coxsackie B was the most com-
mon cause [4]. Other viruses included adeno-, varicella
zoster, cytomegalie and Epstein–Barr. In the presence,
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found in endomyocardial biopsies [5–10].
Clinical symptoms, the course and diagnostic
approach in patients with suspected myocarditis
Clinical symptoms, such as weakness, palpitations, fatigue,
are often minor and are mistaken in many cases as part of
the previous infection or delayed convalescence. However,
sudden cardiac death in persons active in sports—espe-
cially with people younger than 35 years—is often due to
non-detected acute myocarditis [11].
In virus myocarditis, the acute phase of the disease is
triggered by the entry and proliferation in the myocardium
of the causative virus. Various cytokines are activated.
Circulating levels of plasma tumour necrosis factor and
various interleukins are elevated [12, 13]. Inﬁltrating T
lymphocytes and macrophages can be detected in the acute
and chronic phase by biopsy [14]. The acute phase of
myocarditis is characterised by myocyte necrosis and cel-
lular inﬁltrates in the myocard whereas in case of chronic
myocarditis no myocyte necrosis but cellular inﬁltrates
could be detected. Not only in the chronic phase but also in
the acute phase, deterioration of the left function and
dilated cardiomyopathy may occur [13]. Ku ¨hl et al. [5]
demonstrated that patients with persisting viral genomes
detected by myocardial biopsy showed a progressive
impairment of left ventricular function, whereas sponta-
neous viral elimination was associated with a signiﬁcant
improvement in left ventricular function. In contrast to this
ﬁnding, Kindermann et al. [15] found in 181 consecutive
patients who underwent endomyocardial biopsy as part of
an evaluation for clinically suspected myocarditis that for
the primary end point of cardiac death or heart transplan-
tation, NYHA functional classes III and IV, high values of
the left ventricular end-diastolic diameter index and pres-
sure, a low ejection fraction, and immunohistological
detection of inﬂammation were shown to be signiﬁcant
predictors of poor outcome in the univariate analysis,
whereas the Dallas criteria and viral genome detection
were not signiﬁcantly related to outcome. The difference
might be due to patient population, sample collection and
the fact that in the study by Ku ¨hl et al. [5] the patients were
reanalysed by endomyocardial biopsy at a median period of
6.8 months (range 5.4–11.9) which was not performed in
the study by Kindermann et al. [15]. Thus, it is not known
in which patients a clearance of the viral genomes
occurred.
Electrocardiography and laboratory values
ST segment and T-wave abnormalities are the typical
electrocardiographic patterns, but they are usually
transient. Other electrocardiographic abnormalities include
atrial and ventricular arrhythmias, AV and intraventricular
conduction defects and variant early repolarisation [16,
17]. But there exist several patients without electrocar-
diographic abnormalities. Eckart et al. [17] found in
patients with vaccinia-associated myopericarditis despite
markedly elevated cardiac enzymes in 25% a normal
electrocardiogram. Routine laboratory investigations
include troponin T or I, myoglobine, and creatine kinase
levels. Raised troponin levels reﬂect myocardial necrosis
[18]. There are a large number of causes of an elevated
troponin, which include acute coronary syndrome, myo-
carditis, cardiomyopathy, cardiac contusion, aortic dissec-
tion, congestive heart failure, amyloidosis and non-cardiac
causes including pulmonary embolism, sepsis and renal
failure [19–21]. In patients with acute chest pain, elevated
troponin and unobstructed coronary arteries, myocarditis is
a common cause [14, 22]. But there are several patients
with normal electrocardiogram and negative troponin or
creatine kinase levels but suspected myocarditis especially
after or during a viral infection of the respiratory or gas-
trointestinal tract. Carniel et al. [23] found in a consecutive
series of autopsies of fatal myocarditis an elevated creatine
kinase only in 18% of the patients. In addition, even in
patients with ECG changes, these are non-speciﬁc for
myocarditis [3].
Echocardiography
Traditional echocardiographic ﬁndings are left ventricular
regional or global dysfunction, and left ventricular dilata-
tion. Pinamonti et al. [24] found in 41 patients with his-
tologically proven myocarditis left ventricular dysfunction
in 69%, right ventricular dysfunction in 23%, asynergic
ventricular areas in 64%, left ventricular ‘‘hypertrophy’’
sometimes reversible in 20%, ventricular thrombi in 15%
and ‘‘restrictive’’ ventricular ﬁlling in 7% of his patients.
Right ventricular function is an independent predictor of
outcome. Mendes et al. [25] assessed the predictive value
of right ventricular systolic function in patients with active
myocarditis in 23 patients with biopsy-conﬁrmed myocar-
ditis. Initial left ventricular ejection fraction was signiﬁ-
cantly lower in patients with depressed right ventricular
function (27.5 ± 4.9%) compared with that in patients
with normal right ventricular function (47.5 ± 6.3%)
(P = 0.01). The likelihood of an adverse outcome, deﬁned
as death or need for cardiac transplantation, was greater in
patients with abnormal right ventricular function.
The presence of myocardial interstitial oedema in acute
myocarditis leads to thickening of the ventricular wall,
which can be detected by echocardiography [26]. Felker
et al. [27] distinguished fulminant myocarditis with rapid
onset of illness with severe haemodynamic compromise
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123from acute myocarditis by echocardiographic criteria of
septal thickness and left ventricular dimensions. Patients
with fulminant myocarditis had near normal left ventricular
dimensions (5.3 ± 0.9 cm) but increased septal thickness
(1.2 ± 0.2 cm) at presentation, while those with acute
myocarditis had increased diastolic dimensions (6.1 ±
0.8 cm, P\0.01 vs. fulminant) but normal septal thickness
(1.0 ± 0.1 cm, P = 0.01 vs. fulminant). Fulminant myo-
carditis has a better long-term prognosis than acute myo-
carditisasshownintheclinicalstudyofMcCarthyetal.[28].
There are few case reports of detecting myocarditis by
novel echocardiographic modalities such as tissue Doppler,
strain and strain rates or three-dimensional echocardiog-
raphy [29–31]. Di Bella et al. [29] report a case where
strain Doppler echocardiography was able to identify lon-
gitudinal segmental myocardial dysfunction derived from
oedema in the acute phase of myocarditis. Smedema [30]
demonstrates in a case report the value of tissue Doppler
echocardiography and contrast-enhanced cardiac magnetic
resonance imaging (CMRI) in the diagnosis and manage-
ment of patients with myocarditis. Tissue Doppler imaging
demonstrated abnormalities suggestive of myocardial scar,
which was conﬁrmed by magnetic resonance. Thuny et al.
[31] revealed by real-time two- and three-dimensional
echocardiography in a 43-year-old man with myocarditis a
dilated and hypokinetic left ventricle and massive biven-
tricular thrombosis that was better assessed by real-time,
three-dimensional transthoracic echocardiogram.
Nuclear medicine techniques
Gallium-67
In the early 80 s, scintigraphy has been used in evaluating
myocarditis. O’Connell et al. [32] evaluated the applica-
bility of gallium-67 myocardial imaging as an adjunct to
endomyocardial biopsy in the diagnosis of myocarditis in
68 patients with dilated cardiomyopathy. Histologic myo-
carditis was identiﬁed in only 8% of biopsy specimens. Five
of six biopsy samples (87%) with myocarditis showed dense
gallium-67 uptake, whereas only 9 of 65 negative biopsy
samples (14%) were paired with equivocally positive gal-
lium-67 scans (P\0.001). The introduction of single
photon emission computed tomography (SPECT) improved
the differentiation between pericardial and myocardial
localisation which was difﬁcult with planar images alone
[33, 34]. The use of gallium imaging has diminished over
time mainly because of a lack of speciﬁcity [35].
Indium-111
In 1976, Khaw et al. [36] reported a speciﬁc localisation of
a puriﬁed antibody against cardiac myosin. Intravenously
administered radioiodine-labelled antimyosin was selec-
tively localised in infarcted myocardium of seven dogs
24 h after coronary occlusion. Yasuda et al. [37] were the
ﬁrst who reported the use of an indium 111-monoclonal
antimyosin antibody imaging in the diagnosis of acute
myocarditis. Because indium 111-monoclonal antimyosin
antibody imaging can be used to detect myocardial
necrosis, they performed this procedure on 28 patients
clinically suspected of having myocarditis, and compared
the results with those of right ventricular biopsy performed
within 48 h of the scan. Antimyosin scans were positive in
17 patients and negative in 11. Biopsy was positive in nine
patients and negative in six. The remaining showed non-
speciﬁc changes. All patients with biopsy-proven myocar-
ditis had positive antimyosin scans. In addition, eight
patients with no evidence of myocarditis on biopsy had
positive antimyosin scans. On the basis of a right ventric-
ular biopsy standard, the sensitivity of this method was
100%, the speciﬁcity 58%. Ku ¨hl et al. [38] compared the
results of antimyosin scintigraphy in patients with clini-
cally suspected myocarditis with histologic and immuno-
histologic ﬁndings in the endomyocardial biopsy. They
found that, with immunohistologic analysis as the reference
method, antimyosin scintigraphy had a high speciﬁcity but
a lower sensitivity for the detection of myocarditis. During
the following years, the results were conﬁrmed by others
[39–42]. During more than 20 years, antimyosin scans
remained an important cornerstone in the diagnosis of
myocarditis [43].
Other tracers
Myocardial perfusion imaging with technetium-99 m-
labelled methoxyisobutyl isonitrile SPECT (99mTc-MIBI
SPECT) has proven to be an important clinical procedure
in assessing the severity of myocardial ischaemia [44]. The
uptake and clearance of 99mTc-MIBI by the myocardium
is affected by cell viability and membrane integrity. Con-
sequently, infectious diseases, such as myocarditis, may
also affect myocardial perfusion by inducing local
inﬂammation and necrosis. Sun et al. [44] compared
99mTc-MIBI SPECT with other heart monitoring methods
in order to assess its value in the diagnosis of children with
Coxsackie viral myocarditis. The results of their study
suggest that the presence of myocardial uptake of 99mTc-
MIBI may be a marker of myocardial inﬂammation and
necrosis. Thallium-201 myocardial perfusion defects at
rest, suggestive of ﬁbrosis evoked by myocarditis, were
examined in orienteers and athletes [45], but no differences
were found. These and other tracers have not often been
used in clinical practise.
In conclusion, indium-111 antimyosin antibody imaging
has been intensively used during more than two decades for
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123diagnosis of myocarditis. Limitation of this technique
includes its current limited availability in the US [46]
radiation exposure, which is especially of concern in
younger patients and 48-h delay in obtaining imaging after
injection to prevent blood pool effects. Therefore, the
application has diminished over the last years
Cardiac magnetic resonance imaging
During the passed decade, CMRI has emerged as an
important procedure in the investigation of cardiovascular
disease. With this technique, it is possible to analyse
functional parameters such as left ventricular function,
regional wall motion, dimensions and ﬂow properties. In
addition, it can characterise tissue to a greater degree than
other imaging modalities and detect focal or global
inﬂammation [6, 47].
T1-weighted images before and after gadolinium
enhancement
Gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA)
is an approved extracellular T1-enhancing contrast agent
[48] which enhances membrane permeability and capillary
blood ﬂow resulting in an increase in volume of distribu-
tion. Tissue hyperemia is an integral component of the
acute inﬂammatory reaction of the myocardium. Diffuse
myocyte injury can also increase the volume of distribution
and subsequently the extraction fraction of extracellular
compounds such as Gd-DTPA, resulting in abnormal
myocardial enhancement [47, 49].
The group of Friedrich and Schulze-Menger et al. [47,
49] examined T1-weighted images, especially contrast
media-enhanced, in comparison to healthy volunteers in
patients with suspected myocarditis (acute phase). They
found an increased global relative signal enhancement of
the left ventricular myocardium compared to skeletal
muscle in patients compared to volunteers. Roditi et al.
[50] assessed a combination of different techniques
including T1 spin echo before and after gadolinium
enhancement in 12 patients with suspected acute myocar-
ditis. Ten of 12 patients in the myocarditis group showed
focal myocardial enhancement with associated regional
wall motion abnormalities. Laissy et al. [51] prospectively
compared the value of different CMRI modalities in
patients with acute myocarditis. Subtraction Gd-DTPA-
enhanced T1-weighted CMRI accurately identiﬁed myo-
cardial involvement. Gutberlet et al. [52] retrospectively
compared the diagnostic accuracy of three CMRI approa-
ches for the detection of histologic and immunohistologic
criteria proved myocardial inﬂammation in patients
clinically suspected of having chronic myocarditis. The
sensitivity, speciﬁcity and diagnostic accuracy of the
T1-weighted imaging after contrast agent administration
compared with the immunohistologic detection of inﬂam-
mation were 62, 86 and 72%.
The relationship of CMRI ﬁndings to long-term out-
come was studied in another study [53] by serial CMRI
studies in 16 patients with acute myocarditis who were
followed for 2–3 years. Myocardial contrast enhancement
was monitored using contrast-enhanced T1-weighted fast
spin echo images. Contrast enhancement 4 weeks after
onset of symptoms was predictive for the functional and
clinical long-term outcome.
There are some methodical concerns regarding T1
contrast-enhanced images: ﬁrst, it is difﬁcult to establish
stable conditions after the application of Gd-DTPA. There
is a continuous change of the zero run through after the
application of the contrast media. Thus, it is a crucial point,
at which time the images are performed. Secondly, the T1-
weighted images after Gd-DTPA are related to skeletal
muscle. Thus, the relative enhancement depends on the
assumption that the skeletal muscles exhibit a ‘‘normal’’
pattern of gadolinium enhancement. This assumption is
wrong if the inﬂammatory process involves skeletal mus-
cles as well [49]. Thirdly, T1 contrast-enhanced images in
the diagnosis of myocarditis are only published by few
investigators. Therefore, before a routine use of this image
approach is used in daily practise, more studies from dif-
ferent centres should be performed. A native T1-weighted
CMR sequence is, of course, of clinical use in the differ-
entiation of pericardial effusion which may accompany
myocarditis.
T2-weighted images
The tissue T2 relaxation time is an indicator of tissue water
content, which is increased in inﬂammation or necrosis, i.e.
during early myocardial infarction or myocarditis [49, 54].
Gagliardi et al. [55, 56] published two case series on the use
of CMR for non-invasive diagnosis of acute myocarditis.
Compared with biopsy, T2-weighted spin echo CMRI
sequences were found to have a high sensitivity and spec-
iﬁcity. There are some case reports on patients with acute
myocarditis using T2-weighted images to visualise tissue
oedema [40, 57]. However, Friedrich et al. [47] found no
signiﬁcant myocardial signal increase in conventional T2-
weighted images in 44 patients. These images are suscep-
tible to motion, and in native T2-weighted images the image
quality of the myocardium is poor. In addition, the protocols
were different and he used an 1.0 T hardware. New hard-
and software developments, especially a triple inversion
press hold sequence with short acquisition time (STIR),
have led to a much better image quality.
In the study by Abdel-Aty et al. [49], they used a STIR
sequence as well. The increase in T2 signal intensity
756 Clin Res Cardiol (2009) 98:753–763
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with suspected myocarditis (n = 25) from control subjects
(n = 24). We used in a series of 44 consecutive patients
with suspected myocarditis after respiratory tract infection
a STIR sequence as well. We found a signiﬁcant difference
between patients and controls in global myocardial signal
intensity and in the ratio of global myocardial signal
intensity/muscle signal intensity. The sensitivity was
77.8%, the speciﬁcity 90.5%, the positive predictive value
93.3%, and the negative predictive value 70.4%, and the
diagnostic accuracy 82.5%. In addition, the signal intensity
of the septum, anterior and lateral wall was highly signif-
icant from controls [58] (Figs. 1, 2). Assomull et al. [22]
and Gutberlet et al. [52] used novel T2-weighted sequences
as well with good results in detecting myocarditis.
In conclusion, in patients clinically suspected of having
myocarditis, a STIR sequence seems to have a good sen-
sitivity, speciﬁcity and diagnostic accuracy in detecting
tissue oedema, a substantial feature of the inﬂammatory
reaction in the myocardium.
Late enhancement technique
Cardiac magnetic resonance imaging techniques have been
applied to identify viable myocardium and distinguish it
from myocardial necrosis [59] (Fig. 3). Normal myocar-
dium does not enhance because extracellular magnetic
resonance contrast agents, such as Gd-DTPA, are excluded
from the myocyte intracellular space by intact sarcolemmal
membranes and also, little interstitial space is available
between densely packed myocytes [60]. This technique has
been shown to be effective, in both animals and humans, in
identifying the presence, location and extent of acute and
chronic myocardial infarction [59, 61]. The cellular
mechanisms responsible for contrast enhancement have not
been fully elucidated. The hypothesis is that in acutely
infarcted regions the myocyte membranes are ruptured
allowing the cardiovascular magnetic resonance contrast
agent to passively diffuse into the intracellular space,
resulting in increased tissue-level contrast agent concen-
tration and therefore hyperenhancement [60].
The same mechanism may explain contrast enhance-
ment in the setting of inﬂammatory heart disease. Images
acquired late (10–20 min) after application of paramag-
netic contrast agents provide a sensitive tool for detection
of myocardial ﬁbrosis, which is distinguished by bright late
enhancement regions where the contrast lingers in the
extracellular spaces of scarred myocardium [62]. The
major difference to infarcted regions is that areas of tissue
damage within a myocarditic focus are usually smaller than
in infarcts. Islands of necrotic cells are dispersed in a
‘‘cougar-like pattern’’ throughout the focus [52, 63].
Fig. 1 Cardiovascular magnetic resonance image. Short-axis image
of a 54-year-old female patient with acute myocarditis. T2-weighted
image showing oedema of the septum, inferior and lateral wall
(arrow). The patient had biopsy-proven myocarditis of isolated
parvovirus B19 infection. LV Left ventricle. RV right ventricle
Fig. 2 Short-axis T2-weighted image of a control. There is a
homogeneous signal of the myocardium. LV Left ventricle. RV right
ventricle
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visualised in patients with hypertrophic or dilatative car-
diomyopathy [64]. CMRI has been examined in other
cardiac diseases as well [65–69]. There are several case
reports of the usefulness of delayed contrast-enhanced
magnetic resonance imaging for the detection of myocar-
ditis [70–72]. In controlled studies with patients suspected
to have myocarditis, delayed contrast-enhanced cardiac
magnetic resonance has been investigated as well [22, 49,
51, 73–75]. A typical subepicardial/midmyocardial late
contrast enhancement is highly predictable of myocarditis
in suspected patients [48, 75, 76] (Figs. 4, 5).
Cardiac magnetic resonance imaging studies are mainly
performed in the acute phase of myocarditis. Mahrholdt
et al. [6] found a pathological late gadolinium enhancement
in 83 of 87 patients with conﬁrmed acute myocarditis.
Patients without histopathological evidence of myocarditis
did not have late gadolinium enhancement except for one
patient diagnosed with cardiac amyloidosis. In the setting
of parvovirus B19 myocarditis, late gadolinium enhance-
ment was located predominantly in the lateral wall of the
left ventricle, typically originating from the epicardial
quartile (n = 49). This was completely different from
patients with human herpesvirus 6 myocarditis (n = 16), in
whom pathological delayed enhancement was most fre-
quently found in the anteroseptal region, often located
intramurally, without any contact with the subepicardial
region. In the setting of combined parvovirus B19/human
herpesvirus 6 myocarditis, the pattern was similar, not only
affecting the anteroseptal myocardium but also forming a
mid-wall area of damage in the entire septum. Myocardial
biopsies targeted to areas with late gadolinium
Fig. 3 Delayed enhancement imaging of a 50-year-old male patient
with a chronic myocardial infarction. Short-axis view. There is a
transmural scar of the inferoseptal wall (arrow). LV Left ventricle. RV
right ventricle
Fig. 4 Delayed enhancement imaging of a 42-year-old male patient
with viral myocarditis, exertional dyspnoe after a gastrointestinal
infect. Short-axis view demonstrating a small enhanced mid-wall
signal intensity of the left ventricular septum (arrow). LV Left
ventricle. RV right ventricle
Fig. 5 Delayed enhancement imaging of a 61-year-old male patient
with viral myocarditis, fatigue and frequent ventricular premature
beats after a respiratory infect. Four-chamber view demonstrating
enhanced mid-wall signal intensity of the left ventricular septal
myocardium (arrow). LV Left ventricle. RV right ventricle. LA Left
atrium. RA right atrium
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patients [6].
In a study, Gutberlet et al. [52] analysed 83 patients with
chronic myocarditis. They found a lower sensitivity and
accuracy of T1- and T2-weighted images. Their speciﬁcity
was acceptable with 80%. The authors found no association
with polymerase chain reaction proof of viral genomes, but
a correlation with T1- and T2-weighted images and intra-
myocardial inﬂammation. Thus, CMRI ﬁndings have to be
interpreted different if it is used in the acute phase or in the
chronic phase of myocarditis. In the acute phase, an
enhanced signal in T2-weighted images and in T1 contrast-
enhanced images is a typical ﬁnding whereas this is not the
case in chronic myocarditis. At presence, a major limitation
of CMRI is that it cannot detect viral persistence.
In conclusion, in patients with suspected myocarditis,
cardiovascular magnetic resonance tomography including a
high sensitive, speciﬁc and robust fast spin echo triple
inversion recovery sequence (STIR) is helpful in decision-
making. The CMR study should include a late enhance-
ment sequence. T1-weighted native image is recommended
in patients with additional pericardial effusion. T1-weigh-
ted spin echo after gadolinium injection might be added.
Accuracy of cardiovascular magnetic resonance
in relation to biopsy-conﬁrmed cases
The traditional diagnosis of viral myocarditis relies upon
the histological (Dallas) criteria. Evaluation of endomyo-
cardial biopsy specimens by use of these criteria may give
negative results despite clear clinical evidence for acute
myocarditis [3, 49]. There is a sensitivity of only 25–40%
reported [3, 77, 78]. To date, techniques, in particular
immunohistochemistry and viral polymerase chain reac-
tion, and magnetic resonance guided endomyocardial
biopsies have lead to substantial improvement of diag-
nostic accuracy of endomyocardial biopsy [6, 52, 79].
Thus, endomyocardial biopsy remains the diagnostic gold
standard in myocarditis and in viral myocarditis in partic-
ular. Table 1 depicts cardiovascular magnetic resonance in
relation to biopsy-conﬁrmed cases. The majority of the
studies involved only small number of cases. In addition,
there are different methods for the evaluation of myocar-
dial oedema used. In older studies, a T1 spin echo or T2
spin echo sequence was used [49, 50, 55]. In some studies,
no late enhancement technique was performed [49, 50, 55].
Recent studies compared different cardiovascular magnetic
approaches with biopsy results [52, 73], and magnetic
resonance guided endomyocardial biopsies [6]. Especially,
the latter study has shown a very good accuracy between
the late enhancement technique and biopsy-proven myo-
carditis of 95%. In the study of Gutberlet et al. [52], the
diagnostic accuracy was lower (49%). This might be due to
a different state of the patients. A pathological late
enhancement occurs in patients with more severe myo-
carditis which may involve cellular necrosis. Therefore, not
all patients with myocarditis present with a positive late
enhancement pattern. Gutberlet et al. [52] also compared
T1- and T2-weighted images for the diagnosis of myo-
carditis. The diagnostic accuracy was 72 and 68%. Thus,
there is an acceptable concordance between novel magnetic
resonance modalities and biopsy results but still further
research work has to be performed.
Comparison of echocardiography and cardiovascular
magnetic resonance
There are several case reports with normal echocardio-
graphic ﬁndings but a diagnosis of myocarditis was con-
ﬁrmed by cardiac magnetic resonance. Marnach et al. [80]
describe a case of postpartum myocarditis in a woman with
lupus anticoagulant and antiphospholipid syndrome. The
diagnosis of myocarditis was conﬁrmed by cardiac mag-
netic resonance but was not apparent on echocardiography.
The myocarditis resolved with steroid therapy. Kontogi-
anni et al. [81] report two male adolescents (15 and
19 years old) who were admitted due to chest pain inﬂu-
enced by the respiratory movements, composing a clinical
setting highly indicative of acute myocarditis. The echo-
cardiogram performed in both patients failed to reveal any
regional or global wall motion abnormalities or even dia-
stolic dysfunction and remained absolutely normal
throughout their 3-month follow-up period. CMRI within
7 days using T2-weighted and gadolinium-enhanced T1-
weighted images demonstrated extensive focal contrast
enhancement, consistent with acute inﬂammatory myo-
cardial involvement. The authors conclude that contrast
CMRI is a more sensitive method than the echocardiogram
for the diagnosis of acute focal myocarditis.
Computer tomography with multislice techniques
Computer tomography (CT) with multislice techniques is
useful in the diagnosis of coronary artery disease [82].
Brooks and Sane [83] report two patients with clinical
myocarditis who had distinctive ﬁndings at coronary CT.
Both patients demonstrated delayed myocardial enhance-
ment with iodinated contrast. The morphologic features of
the enhancement were similar to the myocardial enhance-
ment with gadolinium contrast on magnetic resonance
imaging recently described in patients with myocarditis,
and different from the enhancement patterns seen in
patients with myocardial infarction. Dambrin et al. [84]
investigated the diagnostic value of ECG-gated multide-
tector CT in the early phase of suspected acute myocarditis
in 12 consecutive patients admitted for suspected acute
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patients had clinical, electrocardiographic signs, and lab-
oratory ﬁndings consistent with the diagnosis. They
compared the CT results to CMRI using T1-weighted
delayed enhancement images after injection of gadolin-
ium. Extent and location of hyperenhancement at CT
correlated well with that observed at MR examination.
Boussel et al. [85] evaluated the accuracy of delayed-
enhanced multidetector computed tomography for differ-
entiating between myocarditis and myocardial infarction
in 12 patients with normal X-ray coronary angiography.
Final diagnosis between myocarditis and myocardial
infarction was identical for delayed-enhanced multidetec-
tor computed tomography and magnetic resonance
tomography with a signiﬁcant agreement for number of
involved segments and transmural extension. A major
limitation of cardiac computed tomography is due to
radiation exposure to the patient. The use of lower tube
voltages, prospective ECG pulsing and new patients pro-
tocols have recently led to dose reduction [86] but still the
applied doses remain relatively high [87].
Conclusion
An autopsy series of consecutive cases have demonstrated
an incidence of myocarditis at approximately 1–10% [88];
on the contrary, myocarditis is seriously underdiagnosed
clinically. In a traditional view, the gold standard has been
myocardial biopsy. However, it is generally speciﬁc but
insensitive for clinical use, mostly because of the focal
nature of the disease. The endomyocardial procedure via
the femoral vein approach under ﬂuoroscopic guidance has
a very low complication rate of 0.0–0.12% of major and
0.2–5.5% of minor complications when performed by very
experienced operators and in a high volume centre [89]. In
clinical practice, the overall rate of complications has been
reported to range between 1 and 6% [79, 90–92]. The
mortality rate has been reported from 0.0 to 0.4% [3, 79,
89–91]. Thus, non-invasive approaches to detect myocar-
ditis are necessary. The traditional diagnostic tools are
ECG, laboratory values, especially troponin T or I, creatine
kinase and echocardiography. For a long period, nuclear
technique with indium-111 antimyosin antibody has been
used as a diagnostic approach. In the last years, the use of
this technique has declined due to radiation exposure and
48-h delay in obtaining imaging after injection to prevent
blood pool effect.
Thus, a non-invasive diagnostic approach without radi-
ation and online image availability has been awaited.
Cardiac magnetic resonance has these promising charac-
teristics. With this technique, it is possible to analyse
inﬂammation, oedema and necrosis in addition to func-
tional parameters such as left ventricular function, regional
wall motion and dimensions. But still larger studies are
warranted to further establish the different CMR modalities
in the diagnosis of myocarditis.
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Table 1 Cardiovascular magnetic resonance in comparison to biopsy-conﬁrmed cases
Literature Number
of pts
Myocardial
oedema present
Late
enhancement
present
Biopsy-
proven active
myocarditis
Accuracy
in regions of late
enhancement
Accuracy in regions
without late
enhancement
Gagliardi et al. [55]1 1 6
a n.p. 6 n.p. n.p.
Friedrich et al. [47] 19 16 (84%) n.p. 4/7 (57%) n.p. n.p.
Roditi et al. [50]2 0 1 2
b n.p. 4 100% n.r.
Mahrholdt et al. [63] 32 n.r. 28 (88%) 20 (62.5%) 19/21 (90%) 1/11 (9%)
De Cobelli et al. [73] 23 5 (22%)
c 16 (70%) 14 (61%) 12/14 (86%) n.r.
Mahrholdt et al. [6] 128 n.r. 83 (95%) 87 n.r. n.r.
Gutberlet et al. [52] 83 72%
d and 68%
e n.r. 49/83 (59%) 49%
f 49%
f
n.r. Not reported, n.p. not performed
a T2 spin echo
b T1-weighted images before and after contrast agent administration
c T2-fat saturated black blood image
d T1-weighted imaging before and after contrast agent administration
e T2-weighted triple inversion recovery imaging to calculate the oedema ratio
f Difference not reported
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